Impel Pharmaceuticals

Late-stage biopharmaceutical company that optimizes drug delivery for central nervous system diseases using its proprietary nasal drug delivery technology

Get these signals delivered weekly

Deals, exits, fundraises, and key hires from funds active in Italy — straight to your inbox.